Previous Article | Next Article 
Journal of Clinical Microbiology, March 2002, p. 1083-1084, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1083-1084.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Neisseria meningitidis Serogroups W135 and A Were Equally Prevalent among Meningitis Cases Occurring at the End of the 2001 Epidemics in Burkina Faso and Niger
Muhamed-Kheir Taha,1 Isabelle Parent du Chatelet,2 Martin Schlumberger,2 Idrissa Sanou,3 Saacou Djibo,4 François de Chabalier,4 and Jean-Michel Alonso1*
Neisseria Unit, National Reference Centre for Meningococci, Institut Pasteur,1
Association pour l'Aide à la Médecine Préventive, 75724 Paris Cedex 15, France,2
Centre Hospitalier National Yalgado Ouedraogo, Ouagadougou 01, Burkina Faso,3
Centre de Recherche sur les Méningites et les Schistosomoses, Niamey, Niger4
Received 10 October 2001/
Returned for modification 5 November 2001/
Accepted 9 December 2001
Meningococcal infections occur as epidemics in the African meningitis belt. Neisseria meningitidis serogroup A is predominantly involved in these epidemics. We report here new data on the involvement of both serogroups A and W135 in meningitis cases in Burkina Faso and Niger at the end of the 2001 epidemic.
* Corresponding author. Mailing address: Neisseria Unit, National Reference Centre for Meningococci, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France. Phone: 33 1 45 68 83 30. Fax: 33 1 40 61 30 34. E-mail: jmalonso{at}pasteur.fr.
Journal of Clinical Microbiology, March 2002, p. 1083-1084, Vol. 40, No. 3
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.3.1083-1084.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Harrison, L. H.
(2008). A Multivalent Conjugate Vaccine for Prevention of Meningococcal Disease in Infants. JAMA
299: 217-219
[Full Text]
-
Nelson, C. B., Birmingham, M., Costa, A., Daviaud, J., Perea, W., Kieny, M.-P., Tarantola, D.
(2007). Preparedness for Infectious Threats: Public-Private Partnership to Develop an Affordable Vaccine for an Emergent Threat: The Trivalent Neisseria meningitidis ACW135 Polysaccharide Vaccine. Am. J. Public Health
97: S15-S22
[Abstract]
[Full Text]
-
Harrison, L. H.
(2006). Prospects for Vaccine Prevention of Meningococcal Infection. Clin. Microbiol. Rev.
19: 142-164
[Abstract]
[Full Text]
-
Jin, Z., Bohach, G. A., Shiloach, J., Norris, S. E., Freedberg, D. I., Deobald, C., Coxon, B., Robbins, J. B., Schneerson, R.
(2005). Conjugates of Group A and W135 Capsular Polysaccharides of Neisseria meningitidis Bound to Recombinant Staphylococcus aureus Enterotoxin C1: Preparation, Physicochemical Characterization, and Immunological Properties in Mice. Infect. Immun.
73: 7887-7893
[Abstract]
[Full Text]
-
Nicolas, P., Norheim, G., Garnotel, E., Djibo, S., Caugant, D. A.
(2005). Molecular Epidemiology of Neisseria meningitidis Isolated in the African Meningitis Belt between 1988 and 2003 Shows Dominance of Sequence Type 5 (ST-5) and ST-11 Complexes. J. Clin. Microbiol.
43: 5129-5135
[Abstract]
[Full Text]
-
Al-Mazrou, Y., Khalil, M., Borrow, R., Balmer, P., Bramwell, J., Lal, G., Andrews, N., Al-Jeffri, M.
(2005). Serologic Responses to ACYW135 Polysaccharide Meningococcal Vaccine in Saudi Children under 5 Years of Age. Infect. Immun.
73: 2932-2939
[Abstract]
[Full Text]
-
Nicolas, P., Djibo, S., Moussa, A., Tenebray, B., Boisier, P., Chanteau, S.
(2005). Molecular Epidemiology of Meningococci Isolated in Niger in 2003 Shows Serogroup A Sequence Type (ST)-7 and Serogroup W135 ST-11 or ST-2881 Strains. J. Clin. Microbiol.
43: 1437-1438
[Abstract]
[Full Text]
-
Taha, M.-K., Giorgini, D., Ducos-Galand, M., Alonso, J.-M.
(2004). Continuing Diversification of Neisseria meningitidis W135 as a Primary Cause of Meningococcal Disease after Emergence of the Serogroup in 2000. J. Clin. Microbiol.
42: 4158-4163
[Abstract]
[Full Text]
-
Tzeng, Y.-L., Noble, C., Stephens, D. S.
(2003). Genetic Basis for Biosynthesis of the ({alpha}1->4)-Linked N-Acetyl-D-Glucosamine 1-Phosphate Capsule of Neisseria meningitidis Serogroup X. Infect. Immun.
71: 6712-6720
[Abstract]
[Full Text]
Copyright © 2002 by the American Society for Microbiology. All rights reserved.